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A growing body of evidence challenges tradi-
tional thinking that only in utero exposures
are of concern for the health of the develop-
ing fetus. Speciﬁcally, reproductive biologists,
epidemiologists, and toxicologists recognize
the potential importance of parental expo-
sures at critical periconceptional windows, in
addition to exposures during organogenesis
(Chapin et al. 2004; Selevan et al. 2000). A
spectrum of human health end points can be
conceptualized for study, as reflected in the
evaluative guidelines set forth by various regu-
latory agencies or organizations (California
Environmental Protection Agency 1991;
European Commission 2002; International
Programme on Chemical Safety 2001; Moore
et al. 1995; U.S. Environmental Protection
Agency 1991, 1996). Recent biomedical
advances offer promise for population-based
studies of this type that can potentially
address the many critical data gaps that
confront this ﬁeld.
Strategies for weighing scientiﬁc evidence
regarding reproductive and developmental
toxicity highlight study design as a criterion
for evaluating the strength of available evi-
dence (Subcommittee on Reproductive and
Developmental Toxicology 2001). Although
experimental study designs present the
strongest data, they are not an ethical option
for assessing the effect(s) of potentially toxic
exposures on human reproductive and devel-
opmental end points. Hence, observational
designs are the sole choice for epidemiologic
investigation. Among observational studies,
data from properly designed and implemented
prospective cohort studies usually receive
more weight than data obtained via retrospec-
tive cohort or case–control studies. This is
mainly because of the investigator’s ability to
ensure a temporal ordering between expo-
sure(s) and outcome(s), measure exposure
more accurately, measure relevant covariates at
multiple time points, and minimize potential
information biases (e.g., recall bias) (Adams
2001; Andersson et al. 2000; Reichman and
Hade 2001; Werler et al. 1989). A recent
example of recall bias in retrospective design is
in a study that found poor reliability and
recall bias in women’s retrospective reports of
exposure to chemicals during pregnancy (Till
et al. 2002). 
Several cohort studies have followed human
development by studying pregnant women
(Golding et al. 2001; Niswander and Gordon
1972). These studies, however, could not
ascertain exposures (or collect biospecimens) at
critical periconceptional windows and could
not assess early reproductive outcomes (before
clinically recognized pregnancy).
The most comprehensive and informative
observational design is a prospective cohort
study that measures exposures longitudinally
(on both parents) beginning prior to preg-
nancy and continuing throughout pregnancy
(if it occurs) and beyond. This study design,
which we call a prospective pregnancy study
with preconception enrollment, allows for the
assessment of early exposures and a complete
range of reproductive and developmental out-
comes, key information for avoiding bias in
evaluating effect(s) of potential toxicants
(Tingen et al. 2004).
Prospective pregnancy studies are often
described as difﬁcult, intensive, and expensive
to conduct, with limited overall yield. In this
article, we examine the empirical evidence on
the utility and feasibility of prospective preg-
nancy study designs for identifying reproduc-
tive and developmental toxicants. Although
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The determinants of successful human reproduction and development may act as early as
periconceptionally, underscoring the need to capture exposures during these critical windows
when assessing potential toxicants. To identify such toxicants, couples must be studied longitudi-
nally prior to conception without regard to a couple’s ability to ascertain a clinically recognized
pregnancy. We examined the utility and feasibility of prospective pregnancy study designs by con-
ducting a systematic review of the literature to summarize relevant information regarding the
planning, implementation, and success of previously published prospective pregnancy studies.
Information concerning design elements and participation was abstracted from 15 eligible studies
(from a total of 20 identiﬁed studies) using a standardized form. The primary author of each study
was contacted to review our summary of their work and obtain missing information. Our ﬁndings
conﬁrm the ability to recruit women/couples from diverse populations using a variety of recruit-
ment strategies. Among the studies we reviewed, 4–97% of eligible individuals were successfully
contacted, with enrollment rates ranging from 42 to 100%. Length of follow-up varied from 3 to
12 months. A high percentage of women provided urine (57–98%) and blood (86–91%) speci-
mens and most male partners (94–100%) provided semen samples. These data support the feasi-
bility of this design. Key words: design, development, fetal, preconception, pregnancy, prospective,
reproduction, toxicity. Environ Health Perspect 112:79–86 (2004). doi:10.1289/ehp.6262 avail-
able via http://dx.doi.org/ [Online 24 September 2003]most prospective pregnancy studies focus on
the determinants of sensitive end points (e.g.,
time to pregnancy and early pregnancy loss), a
review of these issues is beyond the scope of
this article. Our work is based on a systematic
literature review to summarize relevant infor-
mation on the planning, implementation, and
relative success of this design. 
Methods
Search Strategy 
We conducted a MEDLINE (http://www.
ncbi.nlm.nih.gov/entrez/query.fcgl) search in
May 2002 to locate published prospective
pregnancy studies using the following search
terms: prospective studies [MeSH term] AND
(fertility OR fecundity OR time to pregnancy
OR urine OR pregnancy). We sought to iden-
tify all large epidemiologic prospective preg-
nancy studies with preconception enrollment
and at least a 3-month follow-up period. We
reviewed the references cited by each study
investigator to ensure that all relevant pub-
lished works had been identiﬁed. Our initial
search yielded 18 studies, of which 13 were
selected for review. Five studies were excluded
for the following reasons: a) clinical study
focusing on postimplantation pregnancy
(Miller et al. 1980); b) small sample size (n =
24, 13, and 13, respectively) (Hilgers et al.
1978; Li et al. 2002b; Sanders and Bruce
1997), and c) prospective study comprising
only women with clinically recognized preg-
nancies (Li et al. 2002a). We later added two
studies, published while we were ﬁnalizing this
work (Buck et al. 2002; Wang et al. 2003),
which resulted in a total of 15 studies available
for review.
Data Collection 
We developed a standardized data abstraction
form that included author and year of pri-
mary (or methodologically oriented) publica-
tion; size of the target population; number of
individuals contacted; number of eligible
individuals; number of study participants;
length of follow-up; type(s) of data collection,
speciﬁcally, use of daily diaries and biospeci-
men collection (namely, urine and blood);
semen collection; number of people dropping
out of the study; and type(s) of incentives
offered for participation. 
Requests for specific information were
sent to all primary authors in June 2002, with
100% response. The authors were asked to
review and approve our summaries of their
work and to provide missing information if
possible. Both published and unpublished
data obtained from the authors were summa-
rized for our review. Several investigators were
unsure or unable to enumerate the exact size
of the target population, given the sampling
strategy employed. Thus, the eligibility and
participation percentages presented here
should be regarded as best estimates.
Results
Table 1 summarizes the sampling and recruit-
ment strategies of the 15 selected prospective
pregnancy studies. The ﬁrst prospective preg-
nancy study with preconception recruitment
was published in 1984 (France et al. 1984). By
definition and selection, all studies used a
prospective design with women/couples
recruited prior to becoming pregnant. All but
four studies (Brown et al. 1997; Ellish et al.
1996; Hakim et al. 1995; Zinaman et al.
1996) required that women/couples enroll
prior to discontinuing contraception to ensure
that the ﬁrst ovarian cycle, measured in terms
of the menstrual cycle, was at risk for preg-
nancy. Six authors estimated the size of their
target population (Bonde et al. 1998; Brown
et al. 1997; Buck et al. 2002; Ellish et al.
1996; Eskenazi et al. 1995; Hakim et al.
1995). Nine studies did not enumerate a
denominator because of their reliance on com-
munity volunteers responding to recruitment
advertisements or other such attempts to
solicit participation (Colombo and Masarotto
2000; de Mouzon et al. 1988; France et al.
1984; Sweeney et al. 1988, 1989; Vartiainen
et al. 1994; Wang et al. 2003, Wilcox et al.
1988; Zinaman et al. 1996). 
Participants have been recruited from a
number of diverse referent populations (gen-
eral or medical communities, job sites, popula-
tion-based registries), and on the basis of
recreational exposures (e.g., anglers). Most
investigators studied women, with only four
studies focusing on couples (Bonde et al. 1998;
Colombo and Masarotto 2000; de Mouzon
et al. 1988; Zinaman et al. 1996). All but three
studies (Hakim et al. 1995; Sweeney et al.
1988, 1989) were restricted to presumably
fecund women, leaving us with limited under-
standing of the exposure profiles of couples
with impaired fecundity. One author speciﬁ-
cally addressed the yield of mixed recruitment
strategies, with targeted letters being the most
successful (72%), followed by health care
providers (12%), health maintenance
organization (HMO) newsletters (9%), clinic
posters (4%), radio and television announce-
ments (1%), and other methods (2%) (Brown
et al. 1997).
When recruitment details were available
(Table 2), the percentage of women/couples
who were successfully contacted ranged from
2% in a population-based study of ﬁrst preg-
nancy planners (Bonde et al. 1998) to 67% in
a study of women working in the semi-
conductor industry (Eskenazi et al. 1995). Of
particular note is the high percentage of con-
tacts (46%) achieved by one group of investi-
gators by mailing questionnaires to women of
reproductive age who were listed in the New
York State registry of licensed drivers (Ellish
et al. 1996). The percentage of women/cou-
ples successfully contacted or eligible for
enrollment could not be determined for every
study because of the lack of available denomi-
nator information.
The percentage of eligible women/couples
among those who were contacted ranged from
4% in a population-based study that targeted
women of reproductive age (Ellish et al. 1996)
to 95% in a volunteer community-based sam-
ple of couples desiring pregnancy (Zinaman
et al. 1996) and 97% in a group of newly
married textile workers in China (Wang et al.
2003). It should be noted that the number of
women contacted and deemed eligible
appeared to vary according to the recruitment
strategy (i.e., those who publicized their
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Table 1. Target population, sampling unit, and recruitment strategy among the selected prospective
pregnancy studies.
Sampling 
Primary author (year) Target population unit Recruitment strategy
Bonde (1998) Trade union members Couples Letters
Brown (1997) HMO women of reproductive age Women Letters to female HMO members (also 
media and health providers)
Buck (2002) Anglers and partners Women Letters
Colombo (2000) Women seeking medical care Couples Fertility awareness teaching centers
de Mouzon (1988) Community Couples Media and letters
Ellish (1996) Motor vehicle registry Women Letters
Eskenazi (1995) Semiconductor workers Women Letters (also informational meetings)
France (1984) Women seeking medical care Women Media and fertility awareness teachers
Hakim (1995) Semiconductor workers Womena Outreach talks and posters
Sweeney (1988) Community Womena Media and letters
Sweeney (1989) Motor vehicle registry and  Womena Letters
telephone directory
Vartiainen (1994) Community Women Media
Wang (2003) Newly wed textile workers Women Letters
Wilcox (1988) Community Womenb Media
Zinaman (1996) Community Couplesc Media, physician, and acquaintance referral
aThe sampling units were not required to be free of known fecundity or fertility impairments. Media include television,
radio, and newspaper/poster announcements. bMen were enrolled after study was implemented; baseline questionnaire
data available from approximately two-thirds of husbands. (Personal communication with authors.) cFemale partner of
couple had to be free of fecundity impairments.Mini-Monograph | Prospective designs for reproduction and development
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Table 2. Recruitment details for the selected prospective pregnancy studies.a
Primary author 
(country) Year Context Eligibility  criteria Target  (n) Contacts Eligible Participants
Bonde 1998 Couples recruited from  No children 52,255 1,113 (2%) 851 (76%) 430 (51%)
(Denmark) Danish trade unions; ofﬁce  Cohabiting
workers, nurses, and  Age 20–35 (nurses 23–39) years
daycare workers Planning to discontinue contraception
Access to a telephone
Working home freezer
Partner within ± 10 years
Excluded if either partner had previous
reproductive experience
Brown 1997 Participants recruited from  Female HMO member 28,000 2,840 (10%) 1,649 (58%) 1,152 (70%)
(United States) Group Health, Inc., a large  Age 18–35 years
HMO in Minneapolis and  Planning to attempt pregnancy in < 3 months
St. Paul, Minnesota Nulliparas were recruited ﬁrst; multiparas
included later
Multiparas excluded if planned attempt was 
within 12 months of most recent delivery
Excluded if history of > 1 loss at less than 
20 weeks, history of > 2 abortions, history of 
infertility, hypertension, diabetes, heart or 
kidney disease, or if pregnancy plans changed
or pregnancy occurred before planned
Buck 2002 Female members of the New York Indicated that they had not yet started or  2,637 1,031 (39%) 244 (24%) 102 (42%)
(United States) State Angler Cohort Study who  completed childbearing
indicated at enrollment in 1991  Age 18–35 years
that they had not yet completed  Absence of infertility or fecundity problems
childbearing (self-reported)
Colombo 2000 782 women recruited at seven  Women experienced in the use of natural  bb b782
(Europe) European centers (Milan,  family planning
Verona, Lugano, Duesseldorf, Married or in a stable relationship
Paris, London, Brussels);  Age 18–40 years
most were trying to avoid  In multiparas, must have had at least one 
pregnancy menses after delivery/ breastfeeding
Excluded if women were taking hormonal meds
that could affect fertility or if either partner
was sterile or had an endocrine disorder
de Mouzon  1988 Couples in France without a  Absence of contraception during the study  b 4,200 b 1,887
(France) history of infertility who  Existence of at least one eligible menstrual
desired pregnancy cycle
Interpretable cycles
Knowledge of smoking status
Ellish 1996 Women randomly selected from  Off contraception for ≤ 12 months 16,800 7,649 (46%) 293 (4%) 227 (77%)
(United States) the 1987–1988 New York State  Planning to discontinue contraception 
Department of Motor Vehicles within 6 months
database of licensed drivers who  Residence within the prescribed area
were living in Albany County  Regular menstrual cycle length (± 5 days)
when they applied for or renewed
their license
Eskenazi  1995 Women were recruited from  Not currently pregnant 3,915 2,639 (67%) 739 (28%) 481 (65%)
(United States) seven silicon wafer fabrication  Menstruated within the past 2 months
sites in ﬁve U.S. companies Intercourse within the past 2 months
Working home freezer
No plan to leave the company within the 
next 3 months
Ability to speak in English, Spanish, 
Vietnamese, or Tagalog
Excluded if sterilized, using oral contraceptives, 
IUDs, had a sterilized partner, or using 
hormonal steroids that might affect 
fertility
France 1984 Couples contemplating pregnancy  Proven fertility bb b239
(New Zealand) in Auckland, New Zealand, from 
1979 to 1985 who had the desire 
to preselect the sex of their child
Hakim  1995 Female employees at two Proven fertility Over 5,000cb b 148
(United States) semiconductor facilities in  Women desiring pregnancy
Vermont and New York from  42 years of age or younger
May 1989 to August 1991 Excluded if using oral contraceptives, using 
an IUD, or surgically sterilized
(Continued on next page)eligibility criteria during the recruitment
process contacted fewer women, but more of
their contacts were eligible for participation). 
Participation rates seemed to be influ-
enced by both the recruitment strategy and
the study design features, with rates ranging
from 42% of women originally enrolled in a
larger cohort study with a less intense proto-
col to 100% of community volunteers meet-
ing eligibility criteria at one urban medical
center. One group of investigators examined
the degree to which pregnancy intentions
inﬂuenced a woman’s decision to participate
(Sweeney et al. 1989). They found that only
2% of enrolled women reported actively try-
ing to conceive during the 3-month study
period, 46% reported using oral contracep-
tives or intrauterine devices, 24% reported
using barrier methods or monitoring their
cervical mucus and basal body temperature
(BBT) to avoid pregnancy, 18% reported
being sexually inactive, 8% reported being
sexually active but not using contraception,
and 2% reported being infertile. 
Table 3 summarizes the follow-up and
specimen collection details for each selected
study. The length of follow-up varied by
study purpose and intensity of the data collec-
tion. Study durations ranged from 3 to 12
months. The least intensive protocols
included a minimum of baseline interviews
with some prospective recording of relevant
study factors with or without the collection of
biologic specimens. 
Daily diaries were used by 12 (80%) stud-
ies for varying periods of time ranging from
1 month to 12 at-risk menstrual cycles. The
type of data collected with these diaries varied
but typically included exposure(s) of interest,
menstruation, fecundity signs (namely, vagi-
nal mucus discharge and/or BBT), sexual
intercourse, lifestyle behaviors (e.g., cigarette
smoking, alcohol, caffeine, or vitamin/min-
eral consumption, illnesses, medications), and
home pregnancy test results. Among those
studies in which compliance rates were avail-
able, rates ranged from 80 to 98%, with the
exception of one study that reported a 38%
completion rate for the entire study protocol
(France et al. 1984). 
Four types of biospecimens have been col-
lected in prospective pregnancy studies: urine,
blood, semen, and breast milk. Biospecimen
compliance rates were quite high among the
studies for which information was available,
ranging from 57 to 98% for urine, 86 to 93%
for blood, 94 to 100% for semen, and 97% for
a single postpartum breast milk sample. Our
review suggests that once enrolled, women
(and male partners, if applicable) will provide a
variety of specimens for study purposes. 
The reported study dropout rates varied
widely, in part depending on how with-
drawals were handled. (Some authors counted
withdrawals as ineligible.) Moreover, some
investigators requested that women/couples
participate as long as possible, while others
asked a priori for participation for a set period
of time (e.g., 6 months). The lowest dropout
rate (3%) was reported by one group of inves-
tigators in their 6-month prospective preg-
nancy study of community volunteers desiring
pregnancy (Wilcox et al. 1988). France and
associates reported the highest dropout rate
(62%) in their study of couples desiring preg-
nancy who wished to preselect the sex of their
child (France et al. 1984). Of the 148 women
who dropped out of that study, 28% cited a
change in pregnancy plans, 18% stated that
the study was too demanding, 12% felt the
study was too stressful, and 7% failed to
become pregnant. Among other studies
reporting reasons for dropout, the most com-
mon reasons were changes in pregnancy plans
or health status (Bonde et al. 1998; Brown
et al. 1997; Buck et al. 2002; Ellish et al.
1996; Sweeney et al. 1988).
Prospective pregnancy studies have
offered varying levels of incentives for study
participation. Notably, four (27%) authors
reported offering no incentives for participa-
tion (Colombo and Masarotto 2000; Sweeney
et al. 1988, 1989; Vartiainen et al. 1994).
The largest incentive was US$500, which was
given to couples upon completion of a proto-
col that required multiple clinic visits and
sensitive procedures such as midcycle post-
coital tests (Zinaman et al. 1996). Among
U.S. studies reporting the use of incentives,
the smallest was US$10, which was given
either weekly (Wilcox et al. 1988) or every
2 months (Ellish et al. 1996) to women who
Mini-Monograph | Buck et al.
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Table 2. Continued.
Primary author 
(country) Year Context Eligibility  criteria Target  n Contacts Eligible Participants
Sweeney  1988 University of Pittsburgh employees Women trying to become pregnant b 88 b 82
(United States) and other area volunteers who 
were trying to become pregnant 
from October 1985 to October 1986
Sweeney  1989 Women were recruited from a Age 16–44 years bb b104
(United States) particular section of Pittsburgh,  Not currently pregnant
Pennsylvania, in which 89% of  Not menopausal
people were employed in service- Excluded if woman had a history of
oriented and blue-collar jobs hysterectomy
Vartiainen  1994 First-time pregnancy planners  Healthy couples without a history of infertility b 443cb 191
(Finland) were recruited from the Kuopio  Planning to have a baby
area in Eastern Finland
Wang  2003 Newly married female textile  Full-time employment b 1,006c 971 (97%) 961 (99%)
(China) workers in China who intended  Newly married
to conceive Age 20–34 years
Had permission to conceive
Wilcox 1988 Women in the Research Triangle  Age 18 years or older bb b 221c
(United States) Park, North Carolina, area who  Not currently pregnant
were planning to discontinue  Excluded if they had a history of fertility 
contraception problems or chronic illness
Zinaman  1996 Couples discontinuing  Women age 21–37 years b 210 200 (95%) 200 (100%)
(United States) contraception to become  Men age 21–60 years
pregnant Regular menstrual cycles (25–33 days)
Men willing to provide semen samples
Excluded if couples had been without
contraception for > 3 months or if either 
partner had a history of infertility or 
early pregnancy loss
Abbreviations: HMO, health maintenance organization; IUD, intrauterine device. 
aCycles refer to menstrual cycles, whereas months refer to calendar time. bInformation not available. cPersonal communication with author(s).participated in a protocol that included daily
diaries and urine collection (the former had
an attrition rate of 3% and the latter 7%). A
recent study conducted in China paid women
US$1 per three urine samples provided
(Wang et al. 2003). Only two studies reported
providing feedback to participants in the form
of summarized menstrual cycle information
(Buck et al. 2002; Hakim et al. 1995).
Discussion
This review suggests that prospective preg-
nancy studies are a relatively new, powerful,
and feasible design for examining the relation
between biological, environmental, and
lifestyle exposures and various reproductive
and developmental outcomes. The utility of
prospective pregnancy studies has greatly fur-
thered our understanding of human repro-
duction and development, including notable
advances such as estimates of the incidence of
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Table 3. Follow-up and specimen collection details for the selected prospective pregnancy studies.a
Primary author Urine Blood Semen Dropped out 
(country) Year  Participants Length of follow-up Daily diaries samples sample(s) sample(s) of the study Incentive(s) to participate
Bonde 1998 430 (51%) 6 cycles or until  1,329/1,657 Women:  Women:  418/430 35 (8%) $200 for specimens;
(Denmark) pregnancy occurred completed  9,671 (83%) 288/317 (91%) (97%) participants entered in 
(80%) Men:  Men:  a lottery for $3,000b
820 (59%)  350/376 (93%)
Brown 1997 1,152 (70%) 12 cycles, second  N/A N/A N/A N/A 510 (44%) $100 for completion and
(United States) miscarriage, or delivery if  small gifts (e.g., pencils)
pregnancy occurredb with newsletters
Buck 2002 102 (42%) 12 cycles, or until ﬁrst 7 women  N/A 88/102 (86%) N/A 20 (20%) $50 for completion
(United States) postpartum visit or  missing 1+  through postpartum 
cessation of breastfeeding  weekly cardsb blood and breast milk
(if nursing) (97% of women provided 
a postpartum breast milk; 
74% provided a second 
sample upon weaning)b
Colombo 2000 782 Average of 8.6 cycles  80.6% included N/A N/A N/A 300 (25%) Noneb
(Europe) per woman BBT; 85.2%  84 of these
included cervical  women
mucus scoreb re-enteredb
de Mouzon 1988 1,887 12 cycles or until delivery c N/A N/A N/A 687 (36%) c
(France) if pregnancy occurred
Ellish 1996 227 (77%) 12 cycles or until  1,304/1,516  95% N/A N/A 7% $10 for every 2 months of 
(United States) pregnancy occurred (86%) participation; lab results 
completedb were forwarded to 
physiciansb
Eskenazi  1995 481 (65%) 6 cycles or clinical  403 (84%)  84%  N/A N/A 78 (16%) $35 for each month of 
(United States) pregnancy  completed at  completed participation; eligible for
least one cycleb at least  a prize drawing for a trip 
one cycleb to Hawaii or other local 
resort
France 1984 239 6 months or until pregnancy  91 (38%)  c N/A N/A 148 (62%) Personal instruction 
(New Zealand) occurred  completed the  regarding fertility 
entire protocolb awareness and the 
Shettles theory of sex 
selectionb
Hakim 1995 148 At least 6 months or until  Near 100%b 90% N/A N/A 24 (16%)b $100 for completion of 
(United States) pregnancy occurred  the study; feedback on
(mean = 7 cycles) menstrual cycles
Sweeney  1988 82 12 months or until  c Among those N/A N/A 45 (55%) Noneb





Sweeney  1989 104 3 cycles or until the end  81% 80% N/A N/A c Noneb
(United States) of the ﬁrst trimester if 
pregnancy occurred
Vartiainen  1994 191 6 months or until  88% ﬁrstf/u; N/A N/A 180 (94%)b 11 (6%) Noneb
(Finland) pregnancy occurred  59% second f/u;
39% third f/ub
Wang (China) 2003 961 (99%) 12 months or clinically  545 (57%)  545 (57%) N/A N/A 35 (4%) $1 per three urine 
conﬁrmed pregnancy after  completed at  completed at samplesb
stopping contraception least one cycleb least one 
cycleb
Wilcox 1988 221b 6 months or until  98%b 98% N/A N/A 6 (3%) $10/week for urine
(United States) pregnancy occurred  collection
Zinaman  1996 200 (100%) 12 months or until  Over 90%b Over 90%bc 100%  8 (4%) $500 for completion of 
(United States) pregnancy occurred (participation the study
requirement)
Abbreviations: f/u, follow-up; N/A, information not applicable.
aCycles refer to menstrual cycles, whereas months refer to calendar time. bPersonal communication with author(s). cInformation not available.early [i.e., human chorionic gonadotrophin
(hCG) identiﬁed] pregnancy loss and the elu-
cidation of daily and cumulative probabilities
of conception. Such information is crucial for
accurately measuring the reproductive effects
of exposures along the continuum of suscepti-
ble windows of human development.
Although more contacts may be required
to identify a woman eligible for preconception
enrollment in a prospective pregnancy study,
the participation rates of eligible women are
comparable to those seen in prospective stud-
ies of pregnant women. For example, 60% of
eligible women enrolled in the Pregnancy,
Infection, and Nutrition study, a prospective
cohort study of the risk factors for preterm
birth in North Carolina (Siega-Riz et al.
2001). In a captured HMO population, 39%
of the eligible pregnant women were success-
fully recruited to participate in a population-
based prospective cohort study in the Kaiser
Permanente Medical Care Program in
Northern California (Li et al. 2002a).
To address the lack of a sampling frame
for women at risk of pregnancy, one investi-
gator employed commercially available tele-
phone directories (Lobdell et al. 2003). These
inexpensive (< US$100) computerized direc-
tories contain the names, addresses, and tele-
phone numbers of U.S. households, with
each entry linked to basic census information.
The census information enables investigators
to assess sociodemographic differences
between respondents and nonrespondents, as
well as those that could not be reached
because of inaccurate contact information.
Targeted sampling is also possible by weight-
ing or stratifying on ZIP or area code, if a
speciﬁc subpopulation is desired. 
An often-cited concern regarding the utility
of prospective pregnancy studies is that partici-
pants are not representative of pregnant women
as a whole because approximately half of all
pregnancies in the United States are unin-
tended (Henshaw 1998). Approximately 46%
of unintended pregnancies result in live births
(many are electively terminated) (Kaunitz and
Schnare 2001). Little empirical evidence exists
to assess whether the prospective pregnancy
study design results in a biased estimate of effect
because of differing exposure scenarios among
women with intended versus unintended preg-
nancies. However, the possibility of differing
exposure proﬁles should always be given careful
consideration, as women who plan their preg-
nancies are healthier, smoke and drink less, and
have better diets than women who do not
(Brown and Eisenberg 1995). Similarly,
women who change unhealthy or risky behav-
iors are reported to be more educated, more
likely to be employed, and from higher socioe-
conomic backgrounds than women who do not
change behaviors (Beck et al. 2002; Joyce et al.
2000b; Kost et al. 1998). 
Though yet unproven, the xenobiotic
exposure proﬁles of women may also vary by
pregnancy intention status. For example, haz-
ardous waste sites and industrial sources of
environmental pollution are often located in
low-income communities (Farber and Krieg
2002; Morello-Frosch et al. 2002; Wilson et al.
2002) whose residents typically do not partici-
pate in research studies in the absence of tar-
geted recruiting. Further, lifestyle factors such
as cigarette smoking, alcohol use, and medica-
tions can inﬂuence the effects of environmental
chemical exposures in humans (Anwar 1993;
McCauley 1998). Given the potential for dif-
fering exposure profiles among pregnant
women, coupled with the likelihood that some
behaviors will be modiﬁed during pregnancy,
the possible interactive effects of toxic agents
and divergent lifestyle proﬁles during the peri-
conceptional period (including those that are
paternally mediated) must be evaluated.
Prospective pregnancy study designs are the
only reliable approach for such inquiry. 
Additional concerns have been raised
regarding the generalizability of prospective
pregnancy studies because of research suggest-
ing that women with intended pregnancies
have fewer adverse pregnancy outcomes com-
pared with mothers with unintended pregnan-
cies (Piccinino and Mosher 1998). However,
data from the National Longitudinal Survey of
Youth suggest that differences in pregnancy
outcomes by pregnancy intentions might be
explained by the women’s socioeconomic
status rather than by planning status per se
(Joyce et al. 2000a). 
The conceptualization and measurement of
intended or planned pregnancies has recently
come under intense scrutiny, with many
researchers in the field suggesting that more
accurate measures are needed (Klerman 2000;
Luker 1999; Sable 1999; Stanford et al. 2002;
Trussell et al. 1999). For example, one study
reported that 25% of women gave discordant
responses to questions designed to assess preg-
nancy intentions in two large population-based
surveys (Kaufmann et al. 1997). Discrepancies
in pregnancy intention responses were asso-
ciated with age, marital status, income, edu-
cation, parity, time since pregnancy, and
pregnancy outcome. 
As with any epidemiologic investigation,
researchers must weigh the relative importance
of external validity in relation to internal valid-
ity (Grimes and Schulz 2002; Rothman and
Greenland 1998). Given the difﬁculty in deﬁn-
ing the exact size of the population from which
participants in prospective pregnancy studies
are recruited, empirical evaluation of external
validity is often not possible. Although results
from prospective pregnancy studies may not be
generalizable to all women of reproductive age,
they are likely to yield important observations
that prompt additional studies. 
As demonstrated in other pregnancy-
related studies (Wyatt et al. 2002), prospec-
tive pregnancy studies with semen collection
were successful in obtaining specimens from
most male participants (Bonde et al. 1998;
Vartiainen et al. 1994; Zinaman et al. 2000).
Couple-based studies permit exploration of
developmental toxicants that may be medi-
ated through exposure of the embryo or fetus
to the components of seminal ﬂuid via intra-
canicular exposure or by absorbance of semi-
nal ﬂuid components into the bloodstream of
the mother (Benziger and Edelson 1983;
Sandberg et al. 1968). Semen collection pro-
vides the opportunity to measure biological
and chemical components of the seminal ﬂuid
(Lay et al. 2001; Younglai et al. 2002), per-
form standard sperm analyses, and even
examine spermatozoal gene expression proﬁles
(Ostermeier et al. 2002). The routine collec-
tion of semen specimens would further the
assessment of human reproductive function,
as these data could identify paternally medi-
ated developmental effects. Semen analyses
afford an opportunity to identify biomarkers
that could delineate causal mechanisms of
paternal toxicant exposure and/or fertility. 
Our review suggests that study participants
were generally willing to participate in studies
even when they included time-consuming
and/or invasive protocols for extended periods
of time. Future studies may yield even higher
rates of participation as technologic advances
are incorporated into study protocols. Examples
of relatively inexpensive technologies that could
be implemented include specially programmed
handheld devices to record menstrual cycle
symptoms (Wyatt et al. 2002), home fertility
monitors based on daily urine dipsticks (Behre
et al. 2000) or salivary or vaginal probes
(Fehring and Schlaff 1998), one-step luteiniz-
ing hormone tests (Nielsen et al. 2001), ﬁnger-
prick blood spots (Worthman and Stallings
1997), home semen collection (Royster et al.
2000), and mouthwash methods for collecting
genomic DNA (Lum and Le Marchand 1998).
These technologies will be a useful addition to
the biomarkers of fecundity and ovulation cur-
rently in use (e.g., vaginal mucus and BBT)
(Stanford et al. 2002). For example, one recent
study suggests early pregnancies can be detected
with home pregnancy test kits (Buck et al.
2002). These kits have high sensitivity and
speciﬁcity for detecting hCG concentrations of
25 mIU/mL, the level anticipated on the day
following expected menstruation when concep-
tion has occurred (Ehrenkranz 2002). Because
the timing of ovulation can vary in healthy
women, this approach would be most accurate
if used with a marker for ovulation (Wilcox
et al. 2001). 
Our assessment of the utility and feasibility
of prospective pregnancy studies has several
limitations. Only published prospective
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review. Though we made every effort to learn
of all large-scale prospective pregnancy studies
undertaken to date, both published and
unpublished, the possibility remains that we
may have missed some studies. Further,
although it would have been valuable to be
able to include estimates of study costs and
personnel, most investigators were unable to
provide us with that information.
In summary, recruiting women/couples for
prospective pregnancy studies prior to concep-
tion is feasible for both those planning preg-
nancy and those at risk of pregnancy. Among
the population-based studies of women of
reproductive age examined in this review
(Bonde et al. 1998; Brown et al. 1997; Ellish
et al. 1996), the number of participants
divided by the size of the target population
ranged from 0.8 to 4%. Using a conservative
estimate, it therefore appears that about 120
women of reproductive age would need to be
approached to identify one eligible woman/
couple planning pregnancy who might be will-
ing to participate in a study of this type. Our
review suggests that once recruited, women/
couples are often willing to complete very
intensive protocols, even if only a modest
incentive is provided. In one study, when an
urban sample of women was presented with
the choice of four protocols that ranged in
intensity, 74% opted to participate in the most
intense protocol (Sweeney et al. 1989). 
As previously noted, individuals from
underrepresented minority or economically
disadvantaged groups should be targeted for
recruitment, given their potentially higher risk
of exposure to toxicants and possibly greater
susceptibility (Sexton 1997). In so doing,
investigators should consider factors reported
to enhance participation, such as building
trust with community participants (Shavers
et al. 2002). Finally, couples experiencing
fecundity-related impairments, including
those undergoing assisted reproductive tech-
nologies, might represent another group suit-
able for study, in that exposure(s) to toxicants
may be impairing their ability to conceive or
carry a pregnancy to term.
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